Related Experiment Video
Updated: Sep 21, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
PCBP1-mediated regulation of WNT signaling is critical for breast tumorigenesis
Zhao-Ying Yang1, Wen-Long Zhang2, Cheng-Wei Jiang3
1Department of Breast Surgery, China-Japan Union Hospital of Jilin University, No.126, Xiantai Street, Changchun, Jilin, 130033, China.
Abstract:
Loss of expression or protein kinase B (Akt1)-mediated post-translational modification of the RNA binding protein Poly r(C) binding protein 1 (PCBP1) is closely related to metastatic advancement of breast cancer. However, the role of PCBP1 in tumorigenesis is not completely defined. Using a xenograft orthotopic model of breast tumorigenesis (4T1-Pcbp1-/-), we show here that PCBP1 knockdown-induced tumorigenesis is inhibited by activation of the WNT signaling via treating with the glycogen synthase kinase 3 beta inhibitor TWS119, but not the Akt2/Akt3 inhibitor GSK690693. Mass cytometry-based evaluation of the tumor microenvironment (TME) revealed significantly more regulatory T cells (Tregs) and significantly less cytotoxic T cells in 4T1-Pcbp1-/-mice treated with saline control in comparison to mice treated with TWS119. Infiltrating cytotoxic T cells were phenotypically and functionally exhausted. Treatment with TWS119 resulted in rescue of cytotoxic T cell function and inhibition of suppressor activity of Tregs. Using cytotoxic T cells isolated from healthy donors, we show that TWS119-induced WNT signaling-mediated inhibition of cytotoxic T cell expansion is reliant on expression of PCBP1. In conclusion, decreased PCBP1 expression favors breast tumorigenesis by potentiating skewing of tumor infiltrating T cells towards Tregs, thereby effectively suppressing anti-tumor immunity.
Insights
Reduced Poly r(C) binding protein 1 (PCBP1) expression promotes breast cancer growth by increasing regulatory T cells (Tregs) and suppressing cytotoxic T cells. WNT signaling activation inhibits this tumor-promoting effect.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Loss of Poly r(C) binding protein 1 (PCBP1) expression or its post-translational modification by Akt1 is linked to breast cancer metastasis.
- The precise role of PCBP1 in tumor development remains unclear.
Purpose of the Study:
- To investigate the role of PCBP1 in breast tumorigenesis and its impact on the tumor microenvironment (TME).
- To evaluate the therapeutic potential of targeting WNT signaling in PCBP1-deficient breast cancer models.
Main Methods:
- Utilized a 4T1-Pcbp1-/- xenograft orthotopic mouse model of breast cancer.
- Administered WNT signaling activator TWS119 and Akt2/Akt3 inhibitor GSK690693.
- Performed mass cytometry analysis of the TME.
- Isolated and analyzed cytotoxic T cells from healthy donors.
Main Results:
- PCBP1 knockdown-induced tumorigenesis was inhibited by TWS119, but not GSK690693.
- TWS119 treatment increased cytotoxic T cells and decreased regulatory T cells (Tregs) in the TME compared to saline controls.
- Cytotoxic T cells in control mice were exhausted; TWS119 treatment restored their function and reduced Treg suppressive activity.
- PCBP1 expression is essential for WNT signaling-mediated inhibition of cytotoxic T cell expansion.
Conclusions:
- Decreased PCBP1 expression promotes breast tumorigenesis by skewing T cells towards Tregs, suppressing anti-tumor immunity.
- Targeting WNT signaling with TWS119 can counteract the pro-tumorigenic effects of PCBP1 loss by restoring anti-tumor T cell responses.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

